title: Monoclonal antibodies and cytomegalovirus infections.
authors.forename: G
authors.initials: G
authors.lastname: Damaj
authors.forename: A
authors.initials: A
authors.lastname: Charbonnier
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
authors.forename: N
authors.initials: N
authors.lastname: Vey
authors.forename: D
authors.initials: D
authors.lastname: Coso
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab